| Theodore Parks, MD | |
|
1000 E Broad St, Richmond, VA 23219-1930 | |
| (804) 628-0189 | |
| (804) 628-5847 |
| Full Name | Theodore Parks |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1000 E Broad St, Richmond, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114584703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PP0204X | Emergency Medicine - Pediatric Emergency Medicine | 0101275296 (Virginia) | Secondary |
| 208000000X | Pediatrics | 0101275296 (Virginia) | Primary |
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
The consequences of healthcare-associated infections reach well beyond patients' physical health, souring social relationships, and leading some healthcare providers to distance themselves from affected patients, according to a qualitative, systematic review published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction (ED).
Sleep disorders and sleep deficiency are hidden costs that affect employers across America. Seventy percent of Americans admit that they routinely get insufficient sleep, and 30 percent of U.S. workers and 44 percent of night shift workers report sleeping less than six hours per night.
Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T Cells to hone in on and eliminate cancer.
A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.
› Verified 3 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050418000414 |
News Archive
The consequences of healthcare-associated infections reach well beyond patients' physical health, souring social relationships, and leading some healthcare providers to distance themselves from affected patients, according to a qualitative, systematic review published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction (ED).
Sleep disorders and sleep deficiency are hidden costs that affect employers across America. Seventy percent of Americans admit that they routinely get insufficient sleep, and 30 percent of U.S. workers and 44 percent of night shift workers report sleeping less than six hours per night.
Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T Cells to hone in on and eliminate cancer.
A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theodore Parks, MD Po Box 780125, Philadelphia, PA 19178-0125 Ph: (804) 922-4844 | Theodore Parks, MD 1000 E Broad St, Richmond, VA 23219-1930 Ph: (804) 628-0189 |
News Archive
The consequences of healthcare-associated infections reach well beyond patients' physical health, souring social relationships, and leading some healthcare providers to distance themselves from affected patients, according to a qualitative, systematic review published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction (ED).
Sleep disorders and sleep deficiency are hidden costs that affect employers across America. Seventy percent of Americans admit that they routinely get insufficient sleep, and 30 percent of U.S. workers and 44 percent of night shift workers report sleeping less than six hours per night.
Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T Cells to hone in on and eliminate cancer.
A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.
› Verified 3 days ago
Marieka Ann Helou, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 401 N 11th St, Nelson Clinic, 2nd Floor, Room 210, Richmond, VA 23298 Phone: 804-828-9300 | |
Rhoda B Mahoney, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7113 Three Chopt Rd, Suite 101, Richmond, VA 23226 Phone: 804-282-4205 Fax: 804-673-6432 | |
Dr. Tracy Stroma Mcneish, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9900 Independence Park Dr, Suite 100, Richmond, VA 23233 Phone: 804-747-1855 Fax: 804-762-8837 | |
Dr. Burak Gumuscu, MD, PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 5855 Bremo Road, Mob North,, Suite 703, Richmond, VA 23226 Phone: 804-281-8182 | |
Kathryn B Russell, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7113 Three Chopt Rd, Suite 101, Richmond, VA 23226 Phone: 804-282-4205 Fax: 804-673-6432 | |
Jan N. Dalby, NP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7113 Three Chopt Rd, Suite 101, Richmond, VA 23226 Phone: 804-282-4205 Fax: 804-673-6432 | |
Randall Wayne Johnson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7101 Jahnke Rd, 2nd Floor, Richmond, VA 23225 Phone: 804-323-8893 |